Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-30 @ 5:43 PM
Study NCT ID:
NCT04768504
Status:
TERMINATED
Last Update Posted:
2024-11-25
First Post:
2021-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study
Sponsor:
Khashayar Esfahani
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CR2108KE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None